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Thesis Synopsis 
Characterization of the cis and trans acting factors that influence p53 IRES function 
p53 is a nodal tumor suppressor protein that acts as a major defense against cancers. 
Approximately 50% of human tumours have mutations in p53 gene. Among its myriad 
features, the most distinctive is the ability to elicit both apoptotic death and cell cycle arrest. 
p53 has several isoforms. Most of them are produced by either internal promoter activity of 
the gene or alternate splicing of the pre-mRNA. Apart from these mechanisms, p53 mRNA 
has also been shown to be translated into two isoforms, the full-length p53 (FL-p53) and a 
truncated isoform ΔN-p53, which acts as a dominant-negative inhibitor of FL-p53.  
Under conditions of cellular stress, the canonical mode of translation initiation is 
compromised. To maintain the synthesis of proteins important for cell survival and cell-fate 
decisions, a subset of cellular mRNAs utilizes a non-canonical mode of translation initiation. 
The 5’ untranslated region of these mRNAs are highly structured and function as Internal 
Ribosome Entry Site (IRES). Previously, from our laboratory it has been shown that 
translation of p53 and its N-terminally truncated isoform ΔN-p53 can be initiated by IRES 
mediated mechanism. IRES mediated translation of ΔNp53 was maximum at G1-S phase but 
that of FL-p53 was maximum at the G2-M phase. Interestingly in case of a human genetic 
disorder X-linked dyskeratosis congenita (X-DC), aberrant IRES mediated p53 translation 
has been reported. It has also been reported that during oncogenic induced senescence (OIS) 
a switch between cap-dependent to IRES meditated translation occurs in p53 mRNA. From 
our laboratory, we have also demonstrated that polypyrimidine tract binding protein (PTB) 
positively regulates the IRES activities of both the p53 isoforms by shuttling from nucleus to 
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the cytoplasm during genotoxic stress conditions. It is very important to understand how 
these two isoforms are regulated and in turn control the cellular functions.  
In the first part of the thesis, to investigate the importance of the structural integrity of 
the cis acting elements within p53 RNA, we have compared the secondary structure of the 
wild-type RNA with cancer-derived silent mutant p53 RNAs having mutations in the IRES 
elements such as L22L (CTA to CTG) a natural cancer mutation and Triple Silent Mutation 
(mutations were present at the wobble position of codon 17, 18, 19). These mutations result 
in the conformational alterations of p53 IRES RNA that abrogates the IRES function ex vivo 
significantly. It appears that these mutant RNAs failed to bind some trans-acting factors (p37, 
p41/44 etc) which might be critical for the IRES function. By super-shift assay using anti 
hnRNPC1/C2 antibody, we have demonstrated that the TSM mutant showed reduced binding 
to this protein factor. Partial knockdown of hnRNP C1/C2 showed significant decrease in p53 
IRES activity and reduced synthesis of ΔN-p53. Also we have showed that introducing 
compensatory mutations in TSM mutant RNA rescued the secondary structure as well as 
function of p53 IRES. Further, the role of another silent point mutation in the coding 
sequence of p53 was investigated. Silent mutation (CCG to CCA) at codon 36 (P36P) showed 
decreased IRES activity. The mutation also resulted in differential binding of cellular 
proteins. Taken together, our observations suggest pivotal role of some specific trans acting 
factors in regulating the p53-IRES function, which in turn influences the synthesis of 
different p53 isoforms.  
In the second part of the thesis, p53 IRES RNA interacting proteins were identified 
using RNA affinity approach. Annexin A2 and PTB associated Splicing Factor (PSF/SFPQ) 
were identified and their interaction with p53 IRES RNA in vitro and ex vivo was studied. 
Interestingly, in the presence of Ca2+ ions Annexin A2 showed increased binding with p53 
IRES. By competition UV crosslinking we have showed Annexin A2 and PSF interact 
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specifically with p53 IRES. Toe printing assay results showed the putative contact points of 
Annexin A2 and PSF proteins on p53 IRES RNA. Interestingly, both proteins showed 
extensive toe-prints in the neighbourhood of the initiator AUG region of p53. Further, 
competition UV-crosslinking reveals the interplay of these two proteins. Annexin A2 and 
PSF appear to compete each other for binding with p53 IRES. PSF is known to interact with 
PTB protein. Since PTB also interacts with p53 IRES and positively regulates the translation, 
we wanted to study the interplay between PTB and PSF proteins binding with p53 IRES. To 
address this, we have performed competition UV crosslinking experiment and showed that 
increasing concentrations of PTB decreases PSF and p53 IRES interaction. However, 
increasing concentrations of PSF does not decrease or increase in PTB p53 IRES interaction. 
Results suggest that both Annexin A2 and PSF proteins play important role in regulation of 
p53 IRES activity.  
To address the physiological role of Annexin A2 and PSF proteins on p53 IRES 
activity, these proteins were partially knocked down in cellulo. This in turn showed decrease 
in p53 IRES activity in dual luciferase assays as well as in the steady state levels of both the 
p53 isoforms in transient transfection experiments. Heightened or continued expression of 
p53 protein is very important under stress where IRES-dependent translation supersedes 
normal cap-dependent translation. Results showed that expression of Annexin A2 under 
doxorubicin and thapsigargin induced stress are important for maintenance of both p53 IRES 
activity and steady state levels of p53 isoforms. Earlier from our laboratory we have showed 
that the IRES responsible for ∆N-p53 translation is active at G1/S phase while the IRES 
responsible for full length p53 translation is active at G2/M phase. Subcellular localization of 
the trans-acting factors plays a pivotal role in regulation of IRES activity of cellular mRNA. 
In this context we wanted to study the nuclear and cytoplasm localization of Annexin A2 
under different cell cycle stages. We have seen Annexin A2 protein is dispersed in nucleus 
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and cytoplasm at G1/S boundary, but post-G2 phase it moved from nucleus to cytoplasm. 
Further we wanted to investigate the effect of Annexin A2 and PSF on expression of p53 
transactivated genes. Partial knock down of Annexin A2 and PSF proteins showed decrease 
in p21 luciferase activity. By real-time PCR analysis, we have also showed decrease in 
expression of different p53 targets upon silencing of Annexin A2 protein.   
Taken together, our observations suggest pivotal role of cis acting and trans-acting 
factors in regulating the p53-IRES function, which in turn influences the synthesis of p53 
isoforms. 
 
 
 
 
 
 
 
 
 
 
 
                                                                                         
 
 
 
 
